You are here: Industry Insights > biosimilars

News List

Biosimilars that have entered Phase III clinical trials PharmaSources/Caicai
April 23, 2019
Biosimilars that have entered Phase III clinical trials
India to be one of the world’s ‘fastest growing bio’ hubs in 2019: CPhI data biospectrumasia
April 21, 2019
CPhI & P-MEC India 2019 will be returning to the India Expo Centre in the nation’s capital for the second time
Biocon to soon expand its presence in biosimilars in US market expressbpd
April 04, 2019
Dr Mazumdar Shaw, CMD, Biocon said that women must be encouraged to become entrepreneurs
Samsung Bioepis forms new alliance to expand in China pharmaceutical-technology
February 13, 2019
Samsung Bioepis has signed a licensing deal with healthcare-focused private equity firm C-Bridge Capital to accelerate expansion in mainland China....
Thanks to Ocrevus, Roche outgrows biosimilars attack to best quarter of 2018 fiercepharma
February 01, 2019
A major concern at Roche lately has been whether it can keep its head above water in the face of biosimilar challenges.
Humira biosimilars catch fire in Europe and could take half the market in a year fiercepharma
January 28, 2019
AbbVie investors have been bracing for the mother of all patent cliffs—the loss of exclusivity on the company’s $18-billion-per-year Humira—and now its impact is starting to come into view.
Chugai preps filings for IL-6 drug in rare disease, chasing Soliris fiercebiotech
December 20, 2018
Chugai has the positive phase 3 data it needs to file IL-6-targeting antibody satralizumab for approval in neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease, next year.
NICE okays UCB’s Cimzia, nixes Almirall’s Ilumetri, in psoriasis pharmaphorum
December 06, 2018
NICE has recommended in draft guidance that UCB’s Cimzia can receive regular NHS funding for plaque psoriasis, but decided that Almirall’s rival Ilumetri does not represent good value for money.
Mundipharma appoints former GSK exec as CFO pharmaphorum
November 26, 2018
The Mundipharma network of independent pharma companies has appointed Arnaud Breabout as chief financial officer.
Alvotech, Fuji Pharma partner for biosimilars biospectrumasia
November 21, 2018
Partnership gives Fuji Pharma a leading position in the Japanese biosimilar market

Previous page 1 2 3 4 5 6 Next page